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Coronavirus Disease 2019 (COVID-19)
!
On February 11, 2020 the World Health Organization announced an official name for the
disease that is causing the current outbreak of coronavirus disease, COVID-19. CDC will be
updating our website and other CDC materials to reflect the updated name.
Interim Infection Prevention and Control
Recommendations for Patients with Confirmed
Coronavirus Disease 2019 (COVID-19) or Persons
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Background
Infection control procedures including administrative rules and engineering controls, environmental hygiene, correct
work practices, and appropriate use of personal protective equipment (PPE) are all necessary to prevent infections from
spreading during healthcare delivery. Prompt detection and effective triage and isolation of potentially infectious patients
are essential to prevent unnecessary exposures among patients, healthcare personnel, and visitors at the facility. All
healthcare facilities must ensure that their personnel are correctly trained and capable of implementing infection control
procedures; individual healthcare personnel should ensure they understand and can adhere to infection control
requirements.
This guidance is based on the currently limited information available about coronavirus disease 2019 related to disease
severity, transmission efficiency, and shedding duration. This cautious approach will be refined and updated as more
information becomes available and as response needs change in the United States. This guidance is applicable to all U.S.
healthcare settings. This guidance is not intended for non-healthcare settings (e.g., schools) OR to persons
outside of healthcare settings. For recommendations regarding clinical management, air or ground medical transport,
or laboratory settings, refer to the main CDC COVID-19 website.
Frequently Asked Questions: Healthcare Infection Prevention and Control
"
Definition of Healthcare Personnel (HCP) – For the purposes of this guidance, HCP refers to all persons, paid and
unpaid, working in healthcare settings engaged in patient care activities, including: patient assessment for triage, entering
examination rooms or patient rooms to provide care or clean and disinfect the environment, obtaining clinical specimens,
handling soiled medical supplies or equipment, and coming in contact with potentially contaminated environmental
surfaces.
Recommendations
1. Minimize Chance for Exposures
Ensure facility policies and practices are in place to minimize exposures to respiratory pathogens including SARS-CoV-2,
the virus that causes COVID-19. Measures should be implemented before patient arrival, upon arrival, and throughout
the duration of the affected patient’s presence in the healthcare setting.
Before Arrival
When scheduling appointments, instruct patients and persons who accompany them to call ahead or inform
HCP upon arrival if they have symptoms of any respiratory infection (e.g., cough, runny nose, fever1) and to
take appropriate preventive actions (e.g., wear a facemask upon entry to contain cough, follow triage
procedures).
If a patient is arriving via transport by emergency medical services (EMS), the driver should contact the
receiving emergency department (ED) or healthcare facility and follow previously agreed upon local or regional
transport protocols. This will allow the healthcare facility to prepare for receipt of the patient.
Upon Arrival and During the Visit
Take steps to ensure all persons with symptoms of suspected COVID-19 or other respiratory infection (e.g.,
fever, cough) adhere to respiratory hygiene and cough etiquette, hand hygiene, and triage procedures
throughout the duration of the visit. Consider posting visual alerts (e.g., signs, posters) at the entrance and in
strategic places (e.g., waiting areas, elevators, cafeterias) to provide patients and HCP with instructions (in
appropriate languages) about hand hygiene, respiratory hygiene, and cough etiquette. Instructions should
include how to use facemasks (See definition of facemask in Appendix) or tissues to cover nose and mouth
when coughing or sneezing, to dispose of tissues and contaminated items in waste receptacles, and how and
when to perform hand hygiene.
Ensure that patients with symptoms of suspected COVID-19 or other respiratory infection (e.g., fever, cough)
are not allowed to wait among other patients seeking care.  Identify a separate, well-ventilated space that
allows waiting patients to be separated by 6 or more feet, with easy access to respiratory hygiene supplies. In
some settings, medically-stable patients might opt to wait in a personal vehicle or outside the healthcare facility
where they can be contacted by mobile phone when it is their turn to be evaluated.
Ensure rapid triage and isolation of patients with symptoms of suspected COVID-19 or other respiratory
infection (e.g., fever, cough):
Identify patients at risk for having COVID-19 infection before or immediately upon arrival to the healthcare
facility.
Implement triage procedures to detect persons under investigation (PUI) for COVID-19  during or
before patient triage or registration (e.g., at the time of patient check-in) and ensure that all patients
are asked about the presence of symptoms of a respiratory infection and history of travel to areas
experiencing transmission of SARS-CoV-2, the virus that causes COVID-19,  or contact with possible
COVID-19 patients.
Implement respiratory hygiene and cough etiquette (i.e., placing a facemask over the patient’s nose and
mouth if that has not already been done) and isolate the PUI for COVID-19 in an Airborne Infection
Isolation Room (AIIR), if available. See recommendations for “Patient Placement” below. Additional
guidance for evaluating patients in U.S. for COVID-19 infection can be found on the CDC COVID-19
website.
Inform infection prevention and control services, local and state public health authorities, and other
healthcare facility staff as appropriate about the presence of a person under investigation for COVID-19.
Provide supplies for respiratory hygiene and cough etiquette, including 60%-95% alcohol-based hand sanitizer
(ABHS), tissues, no touch receptacles for disposal, and facemasks at healthcare facility entrances, waiting
rooms, patient check-ins, etc.
2. Adherence to Standard, Contact, and Airborne Precautions,
Including the Use of Eye Protection
Standard Precautions assume that every person is potentially infected or colonized with a pathogen that could be
transmitted in the healthcare setting. Elements of Standard Precautions that apply to patients with respiratory infections,
including those caused by COVID-19, are summarized below. Attention should be paid to training on correct use, proper
donning (putting on) and doffing (taking off), and disposal of any PPE. This document does not emphasize all aspects of
Standard Precautions (e.g., injection safety) that are required for all patient care; the full description is provided in the
Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. All HCP (see
section 3 for measures for non-HCP visitors) who enter the room of a patient with known or suspected COVID-19 (i.e.,
PUI) should adhere to Standard, Contact, and Airborne Precautions, including the following:
Patient Placement
Place a patient with known or suspected COVID-19 (i.e., PUI) in an AIIR that has been constructed and
maintained in accordance with current guidelines.
AIIRs are single patient rooms at negative pressure relative to the surrounding areas, and with a minimum
of 6 air changes per hour (12 air changes per hour are recommended for new construction or renovation).
Air from these rooms should be exhausted directly to the outside or be filtered through a high-efficiency
particulate air (HEPA) filter before recirculation. Room doors should be kept closed except when entering
or leaving the room, and entry and exit should be minimized. Facilities should monitor and document the
proper negative-pressure function of these rooms.
If an AIIR is not available, patients who require hospitalization should be transferred as soon as is feasible
to a facility where an AIIR is available. If the patient does not require hospitalization they can be
discharged to home (in consultation with state or local public health authorities) if deemed medically and
socially appropriate. Pending transfer or discharge, place a facemask on the patient and isolate him/her in
an examination room with the door closed. Ideally, the patient should not be placed in any room where
room exhaust is recirculated within the building without HEPA filtration.
Once in an AIIR, the patient’s facemask may be removed. Limit transport and movement of the patient outside
of the AIIR to medically-essential purposes. When not in an AIIR (e.g., during transport or if an AIIR is not
available), patients should wear a facemask to contain secretions.
Personnel entering the room should use PPE, including respiratory protection, as described below.
Only essential personnel should enter the room. Implement staffing policies to minimize the number of HCP
who enter the room.
Facilities should consider caring for these patients with dedicated HCP to minimize risk of transmission
and exposure to other patients and other HCP.
Facilities should keep a log of all persons who care for or enter the rooms or care area of these patients.
Use dedicated or disposable noncritical patient-care equipment (e.g., blood pressure cuffs). If equipment will be
used for more than one patient, clean and disinfect such equipment before use on another patient according
to manufacturer’s instructions.
HCP entering the room soon after a patient vacates the room should use respiratory protection. (See personal
protective equipment section below) Standard practice for pathogens spread by the airborne route (e.g.,
measles, tuberculosis) is to restrict unprotected individuals, including HCP, from entering a vacated room until
sufficient time has elapsed for enough air changes to remove potentially infectious particles (more information
on clearance rates under differing ventilation conditions is available). We do not yet know how long COVID-19
remains infectious in the air. In the interim, it is reasonable to apply a similar time period before entering the
room without respiratory protection as used for pathogens spread by the airborne route (e.g., measles,
tuberculosis). In addition, the room should undergo appropriate cleaning and surface disinfection before it is
returned to routine use.
Hand Hygiene
HCP should perform hand hygiene using ABHS before and after all patient contact, contact with potentially
infectious material, and before putting on and upon removal of PPE, including gloves. Hand hygiene in
healthcare settings also can be performed by washing with soap and water for at least 20 seconds. If hands are
visibly soiled, use soap and water before returning to ABHS.
Healthcare facilities should ensure that hand hygiene supplies are readily available in every care location.
Personal Protective Equipment
Employers should select appropriate PPE and provide it to HCP in accordance with OSHA’s PPE standards (29 CFR
1910 Subpart I) . HCP must receive training on and demonstrate an understanding of when to use PPE; what PPE
is necessary; how to properly don, use, and doff  PPE in a manner to prevent self-contamination; how to properly
dispose of or disinfect and maintain PPE; and the limitations of PPE. Any reusable PPE must be properly cleaned,
decontaminated, and maintained after and between uses. Facilities should have policies and procedures describing
a recommended sequence for safely donning and doffing PPE:
Gloves
Perform hand hygiene, then put on clean, non-sterile gloves upon entry into the patient room or care
area. Change gloves if they become torn or heavily contaminated.
Remove and discard gloves when leaving the patient room or care area, and immediately perform hand
hygiene.
Gowns
Put on a clean isolation gown upon entry into the patient room or area. Change the gown if it becomes
soiled. Remove and discard the gown in a dedicated container for waste or linen before leaving the patient
room or care area. Disposable gowns should be discarded after use. Cloth gowns should be laundered
after each use.
Respiratory Protection
Use respiratory protection (i.e., a respirator) that is at least as protective as a fit-tested NIOSH-certified
disposable N95 filtering facepiece respirator before entry into the patient room or care area. See
appendix for respirator definition.
Disposable respirators should be removed and discarded after exiting the patient’s room or care area and
closing the door. Perform hand hygiene after discarding the respirator.
If reusable respirators (e.g., powered air purifying respirator/PAPR) are used, they must be cleaned and
disinfected according to manufacturer’s reprocessing instructions prior to re-use.
Respirator use must be in the context of a complete respiratory protection program in accordance with
Occupational Safety and Health Administration (OSHA) Respiratory Protection standard (29 CFR 1910.134




a NIOSH-certified disposable N95) and trained in the proper use of respirators, safe removal and disposal,
and medical contraindications to respirator use.
Eye Protection
Put on eye protection (e.g., goggles, a disposable face shield that covers the front and sides of the face)
upon entry to the patient room or care area. Remove eye protection before leaving the patient room or
care area. Reusable eye protection (e.g., goggles) must be cleaned and disinfected according to
manufacturer’s reprocessing instructions prior to re-use.  Disposable eye protection should be discarded
after use.
Use Caution When Performing Aerosol-Generating Procedures
Some procedures performed on COVID-19 patients could generate infectious aerosols. In particular,
procedures that are likely to induce coughing (e.g., sputum induction, open suctioning of airways) should be
performed cautiously and avoided if possible.
If performed, these procedures should take place in an AIIR and personnel should use respiratory protection as
described above. In addition:
Limit the number of HCP present during the procedure to only those essential for patient care and
procedural support.
Clean and disinfect procedure room surfaces promptly as described in the section on environmental
infection control below.
Diagnostic Respiratory Specimen Collection
Collecting diagnostic respiratory specimens (e.g., nasopharyngeal swab) are likely to induce coughing or
sneezing. Individuals in the room during the procedure should, ideally, be limited to the patient and the
healthcare provider obtaining the specimen.
HCP collecting specimens for testing for SARS-CoV-2, the virus that causes COVID-19, from patients with known
or suspected COVID-19 (i.e., PUI) should adhere to Standard, Contact, and Airborne Precautions, including the
use of eye protection.
These procedures should take place in an AIIR or in an examination room with the door closed.  Ideally, the
patient should not be placed in any room where room exhaust is recirculated within the building without HEPA
filtration.
Duration of Isolation Precautions for PUIs and confirmed COVID-19 patients
Until information is available regarding viral shedding after clinical improvement, discontinuation of isolation
precautions should be determined on a case-by-case basis, in conjunction with local, state, and federal health
authorities.
Factors that should be considered include: presence of symptoms related to COVID-19 infection, date
symptoms resolved, other conditions that would require specific precautions (e.g., tuberculosis, Clostridioides
difficile), other laboratory information reflecting clinical status, alternatives to inpatient isolation, such as the
possibility of safe recovery at home.
For additional information refer to the Interim Considerations for Disposition of Hospitalized Patients with
COVID-19.
3. Manage Visitor Access and Movement Within the Facility
Establish procedures for monitoring, managing and training visitors.
Restrict visitors from entering the room of known or suspected COVID-19 patients (i.e., PUI). Alternative mechanisms
for patient and visitor interactions, such as video-call applications on cell phones or tablets should be explored.
Facilities can consider exceptions based on end-of-life situations or when a visitor is essential for the patient’s
emotional well-being and care.
Visitors to patients with known or suspected COVID-19 (i.e., PUI) should be scheduled and controlled to allow for:
Screening visitors for symptoms of acute respiratory illness before entering the healthcare facility.
Facilities should evaluate risk to the health of the visitor (e.g., visitor might have underlying illness putting them
at higher risk for COVID-19) and ability to comply with precautions.
Facilities should provide instruction, before visitors enter patients’ rooms, on hand hygiene, limiting surfaces
touched, and use of PPE according to current facility policy while in the patient’s room.
Facilities should maintain a record (e.g., log book) of all visitors who enter patient rooms.
Visitors should not be present during aerosol-generating procedures.
Visitors should be instructed to limit their movement within the facility.
Exposed visitors (e.g., contact with COVID-19 patient prior to admission) should be advised to report any signs
and symptoms of acute illness to their health care provider for a period of at least 14 days after the last known
exposure to the sick patient.
All visitors should follow respiratory hygiene and cough etiquette precautions while in the common areas of the
facility.
4. Implement Engineering Controls
Consider designing and installing engineering controls to reduce or eliminate exposures by shielding HCP and other
patients from infected individuals. Examples of engineering controls include physical barriers or partitions to guide
patients through triage areas, curtains between patients in shared areas, closed suctioning systems for airway
suctioning for intubated patients, as well as appropriate air-handling systems (with appropriate directionality,
filtration, exchange rate, etc.) that are installed and properly maintained.
5. Monitor and Manage Ill and Exposed Healthcare Personnel
Movement and monitoring decisions for HCP with exposure to COVID-19 should be made in consultation with public
health authorities. Refer to the Interim U.S. Guidance for Risk Assessment and Public Health Management of
Healthcare Personnel with Potential Exposure in a Healthcare Setting to Patients with Coronavirus Disease 2019
(COVID-19) for additional information.
Facilities and organizations providing healthcare should implement sick leave policies for HCP that are non-punitive,
flexible, and consistent with public health guidance.
 6. Train and Educate Healthcare Personnel
Provide HCP with job- or task-specific education and training on preventing transmission of infectious agents,
including refresher training.
HCP must be medically cleared, trained, and fit tested for respiratory protection device use (e.g., N95 filtering
facepiece respirators), or medically cleared and trained in the use of an alternative respiratory protection device
(e.g., Powered Air-Purifying Respirator, PAPR) whenever respirators are required. OSHA has a number of respiratory
training videos .
Ensure that HCP are educated, trained, and have practiced the appropriate use of PPE prior to caring for a patient,
including attention to correct use of PPE and prevention of contamination of clothing, skin, and environment during
the process of removing such equipment.
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7. Implement Environmental Infection Control
Dedicated medical equipment should be used for patient care.
All non-dedicated, non-disposable medical equipment used for patient care should be cleaned and disinfected
according to manufacturer’s instructions and facility policies.
Ensure that environmental cleaning and disinfection procedures are followed consistently and correctly.
Routine cleaning and disinfection procedures (e.g., using cleaners and water to pre-clean surfaces prior to applying
an EPA-registered, hospital-grade disinfectant to frequently touched surfaces or objects for appropriate contact
times as indicated on the product’s label) are appropriate for COVID-19 in healthcare settings, including those
patient-care areas in which aerosol-generating procedures are performed. Products with EPA-approved emerging
viral pathogens claims are recommended for use against COVID-19. These products can be identified by the
following claim:
“[Product name] has demonstrated effectiveness against viruses similar to COVID-19 on hard non-porous
surfaces. Therefore, this product can be used against COVID-19 when used in accordance with the directions
for use against [name of supporting virus] on hard, non-porous surfaces.”
This claim or a similar claim, will be made only through the following communications outlets: technical
literature distributed exclusively to health care facilities, physicians, nurses and public health officials, “1-800”
consumer information services, social media sites and company websites (non-label related). Specific claims for
“COVID-19” will not appear on the product or master label.
See additional information about EPA-approved emerging viral pathogens claims .
If there are no available EPA-registered products that have an approved emerging viral pathogen claim for
COVID-19, products with label claims against human coronaviruses should be used according to label
instructions.
Management of laundry, food service utensils, and medical waste should also be performed in accordance with
routine procedures.
Detailed information on environmental infection control in healthcare settings can be found in CDC’s Guidelines for
Environmental Infection Control in Health-Care Facilities and Guideline for Isolation Precautions: Preventing
Transmission of Infectious Agents in Healthcare Settings [section IV.F. Care of the environment].
8. Establish Reporting within Healthcare Facilities and to Public
Health Authorities
Implement mechanisms and policies that promptly alert key facility staff including infection control, healthcare
epidemiology, facility leadership, occupational health, clinical laboratory, and frontline staff about known or
suspected COVID-19 patients (i.e., PUI).
Communicate and collaborate with public health authorities.
Promptly notify state or local public health authorities of patients with known or suspected COVID-19 (i.e., PUI).
Facilities should designate specific persons within the healthcare facility who are responsible for
communication with public health officials and dissemination of information to HCP.
Appendix: Additional Information about Respirators and Facemasks:
Information about Respirators:
A respirator is a personal protective device that is worn on the face, covers at least the nose and mouth, and is used
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to reduce the wearer’s risk of inhaling hazardous airborne particles (including dust particles and infectious agents),
gases, or vapors. Respirators are certified by the CDC/NIOSH, including those intended for use in healthcare.
Respirator use must be in the context of a complete respiratory protection program in accordance with OSHA
Respiratory Protection standard (29 CFR 1910.134 ). HCP should be medically cleared and fit-tested if using
respirators with tight-fitting facepieces (e.g., a NIOSH-approved N95 respirator) and trained in the proper use of
respirators, safe removal and disposal, and medical contraindications to respirator use.
NIOSH information about respirators
OSHA Respiratory Protection eTool
Filtering Facepiece Respirators (FFR) including N95 Respirators
A commonly used respirator is a filtering facepiece respirator (commonly referred to as an N95). Filtering facepiece
respirators are disposable half facepiece respirators that filter out particles.
To work properly, FFRs must be worn throughout the period of exposure and be specially fitted for each person who
wears one (this is called “fit-testing” and is usually done in a workplace where respirators are used).
Three key factors for an N95 respirator to be effective
FFR users should also perform a user seal check to ensure proper fit each time an FFR is used.
More information on how to perform a user seal check
See a list of NIOSH-approved N95 respirators
Powered Air-Purifying Respirators (PAPRs)
Powered air-purifying respirators (PAPRs) have a battery-powered blower that pulls air through attached filters,
canisters, or cartridges. They provide protection against gases, vapors, or particles, when equipped with the
appropriate cartridge, canister, or filter.
Loose-fitting PAPRs do not require fit testing and can be used with facial hair.
A list of NIOSH-approved PAPRs is located on the NIOSH Certified Equipment List
Information about Facemasks:
If worn properly, a facemask helps block respiratory secretions produced by the wearer from contaminating other
persons and surfaces (often called source control).
Facemasks are cleared by the U.S. Food and Drug Administration (FDA) for use as medical devices. Facemasks
should be used once and then thrown away in the trash.
Interim Guidance for Implementing Home Care of People Not
Requiring Hospitalization for Coronavirus Disease 2019 (COVID-19)
CDC has developed interim guidance for staff at local and state health departments, infection prevention and control
professionals, healthcare providers, and healthcare workers who are coordinating the home care and isolation of people
who are confirmed to have, or being evaluated for coronavirus disease 2019 (COVID-19) (see Criteria to Guide Evaluation





Interim Guidance for Implementing Home Care of People Not Requiring Hospitalization for Coronavirus Disease 2019
(COVID-19)
Important Links and Additional Infection Control Resources




1. Fever may not be present in some patients, such as those who are very young, elderly, immunosuppressed, or
taking certain medications. Clinical judgement should be used to guide testing of patients in such situations.
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